▶ 調査レポート

経皮吸収パッチの世界及び中国市場

• 英文タイトル:Global and China Transdermal Drug Patches Market Insights, Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。経皮吸収パッチの世界及び中国市場 / Global and China Transdermal Drug Patches Market Insights, Forecast to 2027 / QY2108PAL8946資料のイメージです。• レポートコード:QY2108PAL8946
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、149ページ
• 納品方法:Eメール(納期:1日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の当調査資料ではグローバルにおける経皮吸収パッチの市場規模(2016年-2027年)と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、経皮吸収パッチの種類別市場規模(フェンタニル経皮パッチ、ニコチン経皮パッチ、ブプレノルフィン経皮パッチ、クロニジン経皮パッチ、オキシブチニン経皮パッチ、その他)、用途別市場規模(高血圧、避妊、鎮痛、禁煙、狭心症、ホルモン補充療法)も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。
・調査の概要
・調査のサマリー
・世界の経皮吸収パッチ市場動向
・グローバル主要プレイヤーの競争状況・市場シェア
・世界における経皮吸収パッチの種類別市場規模(2016年-2027年):フェンタニル経皮パッチ、ニコチン経皮パッチ、ブプレノルフィン経皮パッチ、クロニジン経皮パッチ、オキシブチニン経皮パッチ、その他
・世界における経皮吸収パッチの用途別市場規模(2016年-2027年):高血圧、避妊、鎮痛、禁煙、狭心症、ホルモン補充療法
・経皮吸収パッチの中国市場分析
- 経皮吸収パッチの中国市場規模(2016年-2027年)
- 中国における経皮吸収パッチの主要プレイヤー別市場シェア
- 中国における経皮吸収パッチの種類別市場規模:フェンタニル経皮パッチ、ニコチン経皮パッチ、ブプレノルフィン経皮パッチ、クロニジン経皮パッチ、オキシブチニン経皮パッチ、その他
- 中国における経皮吸収パッチの用途別市場規模:高血圧、避妊、鎮痛、禁煙、狭心症、ホルモン補充療法
・経皮吸収パッチの北米市場(2016年-2027年)
・経皮吸収パッチのヨーロッパ市場(2016年-2027年)
・経皮吸収パッチのアジア太平洋市場(2016年-2027年)
・経皮吸収パッチの中南米市場(2016年-2027年)
・経皮吸収パッチの中東・アフリカ市場(2016年-2027年)
・主要プレイヤーの情報:Noven、Mylan、Novartis、Johnson & Johnson、Agile Therapeutics、Teikoku Pharma USA、Immune Pharmaceuticals、Hercon Pharmaceuticals、Pocono、DURECT Corporation、Xel Pharmaceuticals
・市場機会・課題・リスク要因分析
・バリューチェーン・販売チャネル分析
・...

A transdermal drug patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal patches are presently being marketed which can be worn anywhere from as little as eight hours to as long as seven days, depending on their therapeutic indication.
In USA, Transdermal Drug Patches key players include Noven, Mylan, Novartis, Johnson & Johnson, etc. Global top four manufacturers hold a share over 85%.
Northeast is the largest market, with a share over 30%, followed by South, and West, both have a share about 50 percent.
In terms of product, Fentanyl Transdermal Patch is the largest segment, with a share about 30%.

Market Analysis and Insights: Global and China Transdermal Drug Patches Market
This report focuses on global and China Transdermal Drug Patches market.
In 2020, the global Transdermal Drug Patches market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Transdermal Drug Patches market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Transdermal Drug Patches Scope and Market Size
Transdermal Drug Patches market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Drug Patches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Transdermal Drug Patches market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others

Segment by Application
Hypertension
Contraception
Analgesia
Smoking Cessation
Angina
Hormone Replacement

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Noven
Mylan
Novartis
Johnson & Johnson
Agile Therapeutics
Teikoku Pharma USA
Immune Pharmaceuticals
Hercon Pharmaceuticals
Pocono
DURECT Corporation
Xel Pharmaceuticals

レポート目次

1 Study Coverage
1.1 Transdermal Drug Patches Product Introduction
1.2 Market by Type
1.2.1 Global Transdermal Drug Patches Market Size Growth Rate by Type
1.2.2 Fentanyl Transdermal Patch
1.2.3 Nicotine Transdermal Patch
1.2.4 Buprenorphine Transdermal Patch
1.2.5 Clonidine Transdermal Patch
1.2.6 Oxybutynin Transdermal Patch
1.2.7 Others
1.3 Market by Application
1.3.1 Global Transdermal Drug Patches Market Size Growth Rate by Application
1.3.2 Hypertension
1.3.3 Contraception
1.3.4 Analgesia
1.3.5 Smoking Cessation
1.3.6 Angina
1.3.7 Hormone Replacement
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Transdermal Drug Patches Market Size, Estimates and Forecasts
2.1.1 Global Transdermal Drug Patches Revenue 2016-2027
2.1.2 Global Transdermal Drug Patches Sales 2016-2027
2.2 Global Transdermal Drug Patches, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Transdermal Drug Patches Historical Market Size by Region (2016-2021)
2.3.1 Global Transdermal Drug Patches Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Transdermal Drug Patches Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Transdermal Drug Patches Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Transdermal Drug Patches Sales Forecast by Region (2022-2027)
2.4.2 Global Transdermal Drug Patches Revenue Forecast by Region (2022-2027)

3 Global Transdermal Drug Patches Competitor Landscape by Players
3.1 Global Top Transdermal Drug Patches Manufacturers by Sales
3.1.1 Global Transdermal Drug Patches Sales by Manufacturer (2016-2021)
3.1.2 Global Transdermal Drug Patches Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Transdermal Drug Patches Manufacturers by Revenue
3.2.1 Key Transdermal Drug Patches Manufacturers Covered: Ranking by Revenue
3.2.2 Global Transdermal Drug Patches Revenue by Manufacturers (2016-2021)
3.2.3 Global Transdermal Drug Patches Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Transdermal Drug Patches Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Transdermal Drug Patches Revenue in 2020
3.2.6 Global Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Transdermal Drug Patches Price by Manufacturers
3.4 Global Transdermal Drug Patches Manufacturing Base Distribution, Product Types
3.4.1 Transdermal Drug Patches Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transdermal Drug Patches Product Type
3.4.3 Date of International Manufacturers Enter into Transdermal Drug Patches Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Transdermal Drug Patches Market Size by Type (2016-2021)
4.1.1 Global Transdermal Drug Patches Sales by Type (2016-2021)
4.1.2 Global Transdermal Drug Patches Revenue by Type (2016-2021)
4.1.3 Transdermal Drug Patches Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Transdermal Drug Patches Market Size Forecast by Type (2022-2027)
4.2.1 Global Transdermal Drug Patches Sales Forecast by Type (2022-2027)
4.2.2 Global Transdermal Drug Patches Revenue Forecast by Type (2022-2027)
4.2.3 Transdermal Drug Patches Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Transdermal Drug Patches Market Size by Application (2016-2021)
5.1.1 Global Transdermal Drug Patches Sales by Application (2016-2021)
5.1.2 Global Transdermal Drug Patches Revenue by Application (2016-2021)
5.1.3 Transdermal Drug Patches Price by Application (2016-2021)
5.2 Transdermal Drug Patches Market Size Forecast by Application (2022-2027)
5.2.1 Global Transdermal Drug Patches Sales Forecast by Application (2022-2027)
5.2.2 Global Transdermal Drug Patches Revenue Forecast by Application (2022-2027)
5.2.3 Global Transdermal Drug Patches Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Transdermal Drug Patches Market Size YoY Growth 2016-2027
6.1.1 China Transdermal Drug Patches Sales YoY Growth 2016-2027
6.1.2 China Transdermal Drug Patches Revenue YoY Growth 2016-2027
6.1.3 China Transdermal Drug Patches Market Share in Global Market 2016-2027
6.2 China Transdermal Drug Patches Market Size by Players (International and Local Players)
6.2.1 China Top Transdermal Drug Patches Players by Sales (2016-2021)
6.2.2 China Top Transdermal Drug Patches Players by Revenue (2016-2021)
6.3 China Transdermal Drug Patches Historic Market Review by Type (2016-2021)
6.3.1 China Transdermal Drug Patches Sales Market Share by Type (2016-2021)
6.3.2 China Transdermal Drug Patches Revenue Market Share by Type (2016-2021)
6.3.3 China Transdermal Drug Patches Price by Type (2016-2021)
6.4 China Transdermal Drug Patches Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Transdermal Drug Patches Sales Forecast by Type (2022-2027)
6.4.2 China Transdermal Drug Patches Revenue Forecast by Type (2022-2027)
6.4.3 China Transdermal Drug Patches Price Forecast by Type (2022-2027)
6.5 China Transdermal Drug Patches Historic Market Review by Application (2016-2021)
6.5.1 China Transdermal Drug Patches Sales Market Share by Application (2016-2021)
6.5.2 China Transdermal Drug Patches Revenue Market Share by Application (2016-2021)
6.5.3 China Transdermal Drug Patches Price by Application (2016-2021)
6.6 China Transdermal Drug Patches Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Transdermal Drug Patches Sales Forecast by Application (2022-2027)
6.6.2 China Transdermal Drug Patches Revenue Forecast by Application (2022-2027)
6.6.3 China Transdermal Drug Patches Price Forecast by Application (2022-2027)

7 North America
7.1 North America Transdermal Drug Patches Market Size YoY Growth 2016-2027
7.2 North America Transdermal Drug Patches Market Facts & Figures by Country
7.2.1 North America Transdermal Drug Patches Sales by Country (2016-2021)
7.2.2 North America Transdermal Drug Patches Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Transdermal Drug Patches Market Size YoY Growth 2016-2027
8.2 Asia Pacific Transdermal Drug Patches Market Facts & Figures by Region
8.2.1 Asia Pacific Transdermal Drug Patches Sales by Region (2016-2021)
8.2.2 Asia Pacific Transdermal Drug Patches Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia

9 Europe
9.1 Europe Transdermal Drug Patches Market Size YoY Growth 2016-2027
9.2 Europe Transdermal Drug Patches Market Facts & Figures by Country
9.2.1 Europe Transdermal Drug Patches Sales by Country (2016-2021)
9.2.2 Europe Transdermal Drug Patches Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Transdermal Drug Patches Market Size YoY Growth 2016-2027
10.2 Latin America Transdermal Drug Patches Market Facts & Figures by Country
10.2.1 Latin America Transdermal Drug Patches Sales by Country (2016-2021)
10.2.2 Latin America Transdermal Drug Patches Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Transdermal Drug Patches Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Transdermal Drug Patches Market Facts & Figures by Country
11.2.1 Middle East and Africa Transdermal Drug Patches Sales by Country (2016-2021)
11.2.2 Middle East and Africa Transdermal Drug Patches Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Noven
12.1.1 Noven Corporation Information
12.1.2 Noven Description and Business Overview
12.1.3 Noven Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Noven Transdermal Drug Patches Products Offered
12.1.5 Noven Recent Development
12.2 Mylan
12.2.1 Mylan Corporation Information
12.2.2 Mylan Description and Business Overview
12.2.3 Mylan Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Mylan Transdermal Drug Patches Products Offered
12.2.5 Mylan Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Description and Business Overview
12.3.3 Novartis Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Transdermal Drug Patches Products Offered
12.3.5 Novartis Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Corporation Information
12.4.2 Johnson & Johnson Description and Business Overview
12.4.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Johnson & Johnson Transdermal Drug Patches Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Agile Therapeutics
12.5.1 Agile Therapeutics Corporation Information
12.5.2 Agile Therapeutics Description and Business Overview
12.5.3 Agile Therapeutics Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Agile Therapeutics Transdermal Drug Patches Products Offered
12.5.5 Agile Therapeutics Recent Development
12.6 Teikoku Pharma USA
12.6.1 Teikoku Pharma USA Corporation Information
12.6.2 Teikoku Pharma USA Description and Business Overview
12.6.3 Teikoku Pharma USA Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Teikoku Pharma USA Transdermal Drug Patches Products Offered
12.6.5 Teikoku Pharma USA Recent Development
12.7 Immune Pharmaceuticals
12.7.1 Immune Pharmaceuticals Corporation Information
12.7.2 Immune Pharmaceuticals Description and Business Overview
12.7.3 Immune Pharmaceuticals Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Immune Pharmaceuticals Transdermal Drug Patches Products Offered
12.7.5 Immune Pharmaceuticals Recent Development
12.8 Hercon Pharmaceuticals
12.8.1 Hercon Pharmaceuticals Corporation Information
12.8.2 Hercon Pharmaceuticals Description and Business Overview
12.8.3 Hercon Pharmaceuticals Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Hercon Pharmaceuticals Transdermal Drug Patches Products Offered
12.8.5 Hercon Pharmaceuticals Recent Development
12.9 Pocono
12.9.1 Pocono Corporation Information
12.9.2 Pocono Description and Business Overview
12.9.3 Pocono Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Pocono Transdermal Drug Patches Products Offered
12.9.5 Pocono Recent Development
12.10 DURECT Corporation
12.10.1 DURECT Corporation Corporation Information
12.10.2 DURECT Corporation Description and Business Overview
12.10.3 DURECT Corporation Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
12.10.4 DURECT Corporation Transdermal Drug Patches Products Offered
12.10.5 DURECT Corporation Recent Development
12.11 Noven
12.11.1 Noven Corporation Information
12.11.2 Noven Description and Business Overview
12.11.3 Noven Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Noven Transdermal Drug Patches Products Offered
12.11.5 Noven Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Transdermal Drug Patches Industry Trends
13.2 Transdermal Drug Patches Market Drivers
13.3 Transdermal Drug Patches Market Challenges
13.4 Transdermal Drug Patches Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Transdermal Drug Patches Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Transdermal Drug Patches Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Fentanyl Transdermal Patch
Table 3. Major Manufacturers of Nicotine Transdermal Patch
Table 4. Major Manufacturers of Buprenorphine Transdermal Patch
Table 5. Major Manufacturers of Clonidine Transdermal Patch
Table 6. Major Manufacturers of Oxybutynin Transdermal Patch
Table 7. Major Manufacturers of Others
Table 8. Global Transdermal Drug Patches Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 9. Global Transdermal Drug Patches Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 10. Global Transdermal Drug Patches Sales by Regions (2016-2021) & (K Units)
Table 11. Global Transdermal Drug Patches Sales Market Share by Regions (2016-2021)
Table 12. Global Transdermal Drug Patches Revenue by Regions (2016-2021) & (US$ Million)
Table 13. Global Transdermal Drug Patches Sales Forecast by Region (2022-2027) & (K Units)
Table 14. Global Transdermal Drug Patches Sales Market Share Forecast by Region (2022-2027)
Table 15. Global Transdermal Drug Patches Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 16. Global Transdermal Drug Patches Revenue Market Share Forecast by Region (2022-2027)
Table 17. Global Transdermal Drug Patches Sales by Manufacturers (2016-2021) (K Units)
Table 18. Global Transdermal Drug Patches Sales Share by Manufacturers (2016-2021)
Table 19. Ranking of Global Top Transdermal Drug Patches Manufacturers by Revenue (US$ Million) in 2020
Table 20. Transdermal Drug Patches Revenue by Manufacturers (2016-2021) (US$ Million)
Table 21. Transdermal Drug Patches Revenue Share by Manufacturers (2016-2021)
Table 22. Global Transdermal Drug Patches Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 23. Global Transdermal Drug Patches by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Drug Patches as of 2020)
Table 24. Key Manufacturers Transdermal Drug Patches Price (2016-2021) (USD/K Units)
Table 25. Transdermal Drug Patches Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Transdermal Drug Patches Product Type
Table 27. Date of International Manufacturers Enter into Transdermal Drug Patches Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Transdermal Drug Patches Sales by Type (2016-2021) (K Units)
Table 30. Global Transdermal Drug Patches Sales Share by Type (2016-2021)
Table 31. Global Transdermal Drug Patches Revenue by Type (2016-2021) (US$ Million)
Table 32. Global Transdermal Drug Patches Revenue Share by Type (2016-2021)
Table 33. Transdermal Drug Patches Average Selling Price (ASP) by Type (2016-2021) & (USD/K Units)
Table 34. Global Transdermal Drug Patches Sales Forecast by Type (2022-2027) & (K Units)
Table 35. Global Transdermal Drug Patches Sales Market Share Forecast by Type (2022-2027)
Table 36. Global Transdermal Drug Patches Revenue Forecast V (2022-2027) & (US$ Million)
Table 37. Global Transdermal Drug Patches Revenue Market Share Forecast by Type (2022-2027)
Table 38. Global Transdermal Drug Patches Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/K Units)
Table 39. Global Transdermal Drug Patches Sales by Application (2016-2021) (K Units)
Table 40. Global Transdermal Drug Patches Sales Share by Application (2016-2021)
Table 41. Global Transdermal Drug Patches Revenue by Application (2016-2021) (US$ Million)
Table 42. Global Transdermal Drug Patches Revenue Share by Application (2016-2021)
Table 43. Transdermal Drug Patches Average Selling Price (ASP) by Application (2016-2021) & (USD/K Units)
Table 44. Global Transdermal Drug Patches Sales Forecast by Application (2022-2027) & (K Units)
Table 45. Global Transdermal Drug Patches Sales Market Share Forecast by Application (2022-2027)
Table 46. Global Transdermal Drug Patches Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 47. Global Transdermal Drug Patches Revenue Market Share Forecast by Application (2022-2027)
Table 48. Global Transdermal Drug Patches Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/K Units)
Table 49. China Transdermal Drug Patches Sales (K Units) of Key Companies (2016-2021)
Table 50. China Transdermal Drug Patches Sales Share by Company (2016-2021)
Table 51. China Transdermal Drug Patches Revenue (US$ Million) by Company (2016-2021)
Table 52. China Transdermal Drug Patches Revenue Share by Company (2016-2021)
Table 53. China Transdermal Drug Patches Sales (K Units) by Type (2016-2021)
Table 54. China Transdermal Drug Patches Sales Share by Type (2016-2021)
Table 55. China Transdermal Drug Patches Revenue (US$ Million) Market Share by Type (2016-2021)
Table 56. China Transdermal Drug Patches Price (USD/K Units) by Type (2016-2021)
Table 57. China Transdermal Drug Patches Sales (K Units) by Type (2022-2027)
Table 58. China Transdermal Drug Patches Sales Share by Type (2022-2027)
Table 59. China Transdermal Drug Patches Revenue (US$ Million) Market Share by Type (2022-2027)
Table 60. China Transdermal Drug Patches Revenue Share by Type (2022-2027)
Table 61. China Transdermal Drug Patches Price (USD/K Units) by Type (2022-2027)
Table 62. China Transdermal Drug Patches Sales (K Units) by Application (2016-2021)
Table 63. China Transdermal Drug Patches Sales Share by Application (2016-2021)
Table 64. China Transdermal Drug Patches Revenue (US$ Million) Market Share by Application (2016-2021)
Table 65. China Transdermal Drug Patches Price (USD/K Units) by Application (2016-2021)
Table 66. China Transdermal Drug Patches Sales (K Units) by Application (2022-2027)
Table 67. China Transdermal Drug Patches Sales Share by Application (2022-2027)
Table 68. China Transdermal Drug Patches Revenue (US$ Million) Market Share by Application (2022-2027)
Table 69. China Transdermal Drug Patches Revenue Share by Application (2022-2027)
Table 70. China Transdermal Drug Patches Price (USD/K Units) by Application (2022-2027)
Table 71. North America Transdermal Drug Patches Sales by Country (2016-2021) & (K Units)
Table 72. North America Transdermal Drug Patches Sales Market Share by Country (2016-2021)
Table 73. North America Transdermal Drug Patches Revenue by Country (2016-2021) & (US$ Million)
Table 74. North America Transdermal Drug Patches Revenue Market Share by Country (2016-2021)
Table 75. Asia Pacific Transdermal Drug Patches Sales by Region (2016-2021) & (K Units)
Table 76. Asia Pacific Transdermal Drug Patches Sales Market Share by Region (2016-2021)
Table 77. Asia Pacific Transdermal Drug Patches Revenue by Region (2016-2021) & (US$ Million)
Table 78. Asia Pacific Transdermal Drug Patches Revenue Market Share by Region (2016-2021)
Table 79. Europe Transdermal Drug Patches Sales by Country (2016-2021) & (K Units)
Table 80. Europe Transdermal Drug Patches Sales Market Share by Country (2016-2021)
Table 81. Europe Transdermal Drug Patches Revenue by Country (2016-2021) & (US$ Million)
Table 82. Europe Transdermal Drug Patches Revenue Market Share by Country (2016-2021)
Table 83. Latin America Transdermal Drug Patches Sales by Country (2016-2021) & (K Units)
Table 84. Latin America Transdermal Drug Patches Sales Market Share by Country (2016-2021)
Table 85. Latin Americaa Transdermal Drug Patches Revenue by Country (2016-2021) & (US$ Million)
Table 86. Latin America Transdermal Drug Patches Revenue Market Share by Country (2016-2021)
Table 87. Middle East and Africa Transdermal Drug Patches Sales by Country (2016-2021) & (K Units)
Table 88. Middle East and Africa Transdermal Drug Patches Sales Market Share by Country (2016-2021)
Table 89. Middle East and Africa Transdermal Drug Patches Revenue by Country (2016-2021) & (US$ Million)
Table 90. Middle East and Africa Transdermal Drug Patches Revenue Market Share by Country (2016-2021)
Table 91. Noven Corporation Information
Table 92. Noven Description and Business Overview
Table 93. Noven Transdermal Drug Patches Sales (K Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 94. Noven Transdermal Drug Patches Product
Table 95. Noven Recent Development
Table 96. Mylan Corporation Information
Table 97. Mylan Description and Business Overview
Table 98. Mylan Transdermal Drug Patches Sales (K Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 99. Mylan Product
Table 100. Mylan Recent Development
Table 101. Novartis Corporation Information
Table 102. Novartis Description and Business Overview
Table 103. Novartis Transdermal Drug Patches Sales (K Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 104. Novartis Product
Table 105. Novartis Recent Development
Table 106. Johnson & Johnson Corporation Information
Table 107. Johnson & Johnson Description and Business Overview
Table 108. Johnson & Johnson Transdermal Drug Patches Sales (K Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 109. Johnson & Johnson Product
Table 110. Johnson & Johnson Recent Development
Table 111. Agile Therapeutics Corporation Information
Table 112. Agile Therapeutics Description and Business Overview
Table 113. Agile Therapeutics Transdermal Drug Patches Sales (K Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 114. Agile Therapeutics Product
Table 115. Agile Therapeutics Recent Development
Table 116. Teikoku Pharma USA Corporation Information
Table 117. Teikoku Pharma USA Description and Business Overview
Table 118. Teikoku Pharma USA Transdermal Drug Patches Sales (K Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 119. Teikoku Pharma USA Product
Table 120. Teikoku Pharma USA Recent Development
Table 121. Immune Pharmaceuticals Corporation Information
Table 122. Immune Pharmaceuticals Description and Business Overview
Table 123. Immune Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 124. Immune Pharmaceuticals Product
Table 125. Immune Pharmaceuticals Recent Development
Table 126. Hercon Pharmaceuticals Corporation Information
Table 127. Hercon Pharmaceuticals Description and Business Overview
Table 128. Hercon Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 129. Hercon Pharmaceuticals Product
Table 130. Hercon Pharmaceuticals Recent Development
Table 131. Pocono Corporation Information
Table 132. Pocono Description and Business Overview
Table 133. Pocono Transdermal Drug Patches Sales (K Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 134. Pocono Product
Table 135. Pocono Recent Development
Table 136. DURECT Corporation Corporation Information
Table 137. DURECT Corporation Description and Business Overview
Table 138. DURECT Corporation Transdermal Drug Patches Sales (K Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 139. DURECT Corporation Product
Table 140. DURECT Corporation Recent Development
Table 141. Xel Pharmaceuticals Corporation Information
Table 142. Xel Pharmaceuticals Description and Business Overview
Table 143. Xel Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 144. Xel Pharmaceuticals Product
Table 145. Xel Pharmaceuticals Recent Development
Table 146. Transdermal Drug Patches Market Trends
Table 147. Transdermal Drug Patches Market Drivers
Table 148. Transdermal Drug Patches Market Challenges
Table 149. Transdermal Drug Patches Market Restraints
Table 150. Transdermal Drug Patches Customers List
Table 151. Transdermal Drug Patches Distributors List
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Drug Patches Product Picture
Figure 2. Global Transdermal Drug Patches Sales Market Share by Type in 2020 & 2027
Figure 3. Fentanyl Transdermal Patch Product Picture
Figure 4. Nicotine Transdermal Patch Product Picture
Figure 5. Buprenorphine Transdermal Patch Product Picture
Figure 6. Clonidine Transdermal Patch Product Picture
Figure 7. Oxybutynin Transdermal Patch Product Picture
Figure 8. Others Product Picture
Figure 9. Global Transdermal Drug Patches Sales Market Share by Application in 2020 & 2027
Figure 10. Hypertension
Figure 11. Contraception
Figure 12. Analgesia
Figure 13. Smoking Cessation
Figure 14. Angina
Figure 15. Hormone Replacement
Figure 16. Transdermal Drug Patches Report Years Considered
Figure 17. Global Transdermal Drug Patches Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Transdermal Drug Patches Market Size 2016-2027 (US$ Million)
Figure 19. Global Transdermal Drug Patches Sales 2016-2027 (K Units)
Figure 20. Global Transdermal Drug Patches Market Size Market Share by Region: 2021 Versus 2027
Figure 21. Global Transdermal Drug Patches Sales Market Share by Region (2016-2021)
Figure 22. Global Transdermal Drug Patches Sales Market Share by Region in 2020
Figure 23. Global Transdermal Drug Patches Revenue Market Share by Region (2016-2021)
Figure 24. Global Transdermal Drug Patches Revenue Market Share by Region in 2020
Figure 25. Global Transdermal Drug Patches Sales Share by Manufacturer in 2020
Figure 26. The Top 10 and 5 Players Market Share by Transdermal Drug Patches Revenue in 2020
Figure 27. Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Transdermal Drug Patches Sales Market Share by Type (2016-2021)
Figure 29. Global Transdermal Drug Patches Sales Market Share by Type in 2020
Figure 30. Global Transdermal Drug Patches Revenue Market Share by Type (2016-2021)
Figure 31. Global Transdermal Drug Patches Revenue Market Share by Type in 2020
Figure 32. Global Transdermal Drug Patches Sales Market Share by Application (2016-2021)
Figure 33. Global Transdermal Drug Patches Sales Market Share by Application in 2020
Figure 34. Global Transdermal Drug Patches Revenue Market Share by Application (2016-2021)
Figure 35. Global Transdermal Drug Patches Revenue Market Share by Application in 2020
Figure 36. China Transdermal Drug Patches Sales Growth Rate 2016-2027 (K Units)
Figure 37. China Transdermal Drug Patches Revenue Growth Rate 2016-2027 (US$ Million)
Figure 38. China Transdermal Drug Patches Market Share in Global Market 2016-2027
Figure 39. China 5 and 10 Largest Transdermal Drug Patches Players Market Share by Revenue in Transdermal Drug Patches in 2020
Figure 40. China Transdermal Drug Patches Revenue Share by Type (2016-2021)
Figure 41. China Transdermal Drug Patches Revenue Growth Rate by Type in 2016 & 2020
Figure 42. China Transdermal Drug Patches Revenue Share by Application (2016-2021)
Figure 43. China Transdermal Drug Patches Revenue Growth Rate by Application in 2016 & 2020
Figure 44. North America Transdermal Drug Patches Sales Growth Rate 2016-2021 (K Units)
Figure 45. North America Transdermal Drug Patches Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. North America Transdermal Drug Patches Sales Market Share by Country in 2020
Figure 47. North America Transdermal Drug Patches Revenue Market Share by Country in 2020
Figure 48. U.S. Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 49. U.S. Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Canada Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 51. Canada Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. Europe Transdermal Drug Patches Sales Growth Rate 2016-2021 (K Units)
Figure 53. Europe Transdermal Drug Patches Revenue Growth Rate 2016-2021 (US$ Million)
Figure 54. Europe Transdermal Drug Patches Sales Market Share by Country in 2020
Figure 55. Europe Transdermal Drug Patches Revenue Market Share by Country in 2020
Figure 56. Germany Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 57. Germany Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. France Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 59. France Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. U.K. Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 61. U.K. Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Italy Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 63. Italy Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Russia Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 65. Russia Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Asia Pacific Transdermal Drug Patches Sales Growth Rate 2016-2021 (K Units)
Figure 67. Asia Pacific Transdermal Drug Patches Revenue Growth Rate 2016-2021 (US$ Million)
Figure 68. Asia Pacific Transdermal Drug Patches Sales Market Share by Region in 2020
Figure 69. Asia Pacific Transdermal Drug Patches Revenue Market Share by Region in 2020
Figure 70. China Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 71. China Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Japan Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 73. Japan Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. South Korea Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 75. South Korea Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. India Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 77. India Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Australia Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 79. Australia Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. China Taiwan Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 81. China Taiwan Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Indonesia Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 83. Indonesia Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Thailand Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 85. Thailand Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Malaysia Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 87. Malaysia Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Latin America Transdermal Drug Patches Sales Growth Rate 2016-2021 (K Units)
Figure 89. Latin America Transdermal Drug Patches Revenue Growth Rate 2016-2021 (US$ Million)
Figure 90. Latin America Transdermal Drug Patches Sales Market Share by Country in 2020
Figure 91. Latin America Transdermal Drug Patches Revenue Market Share by Country in 2020
Figure 92. Mexico Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 93. Mexico Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Brazil Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 95. Brazil Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Argentina Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 97. Argentina Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Middle East and Africa Transdermal Drug Patches Sales Growth Rate 2016-2021 (K Units)
Figure 99. Middle East and Africa Transdermal Drug Patches Revenue Growth Rate 2016-2021 (US$ Million)
Figure 100. Middle East and Africa Transdermal Drug Patches Sales Market Share by Country in 2020
Figure 101. Middle East and Africa Transdermal Drug Patches Revenue Market Share by Country in 2020
Figure 102. Turkey Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 103. Turkey Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Saudi Arabia Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 105. Saudi Arabia Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. UAE Transdermal Drug Patches Sales Growth Rate (2016-2021) (K Units)
Figure 107. UAE Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 108. Transdermal Drug Patches Value Chain
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed